Post-Pandemic Prevalence of SARS-CoV-2 RNA in the Saliva of HIV/AIDS Patients in Jos, Nigeria

Read full text Summarise with VIRAT
Authors: Lipigwe Lauya, Nanma Tongnan Cosmas, Edmund B. Banwat, Nimzing Lohya, Rapp C. Nyam, Godwin Imade, Okonkwo C. Stanley
Cited by: 0
References: 22

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

On May 5, 2023, the World Health Organization (WHO) cautiously declared COVID-19 no longer a global health emergency, because the causative agent, SARS-CoV-2, continues to evolve and is no longer a serious public health threat.This makes surveillance essential, especially for high-risk groups like HIV/AIDS patients.Consequently, this study assessed the post-pandemic prevalence of SARS-CoV-2 RNA in the saliva of HIV/AIDS patients in Jos, Nigeria.This cross-sectional study was conducted across two HIV treatment centers in Jos, where 200 consenting HIV/AIDS patients were recruited using convenience sampling.Eligible participants were aged 18 years and above, unvaccinated against COVID-19, asymptomatic, and had not tested for COVID-19 in the past.From each participant, 2 ml of saliva was collected and processed for RNA extraction using the QIAamp Viral RNA Mini Kit.SARS-CoV-2 RNA detection was performed with the QIAGEN Artus SARS-CoV-2 Pre-amp UM Kit on a Bio-Rad CFX96 RT-PCR platform.Associations between demographics and SARS-CoV-2 status were tested using Chi-square.SARS-CoV-2 RNA was detected in 4 participants (2.0%, with 95% CI), with Ct values of 28.01, 29.57, 29.81, and 33.68.The mean age of the study population was 47.64 ± 10.559 years.All the positive cases occurred among middle-aged groups (38-57 years).No significant associations were found between SARS-CoV-2 status and age (p = 0.824) or sex (p = 0.716).These finding highlight the need to continually monitor the SARS-COV-2 for future evolution and prevalence in the community especially in the context of concurrent infections.

Fields of Study & Subjects

SARS-CoV-2 detection and testing SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies

Publication details

Journal / source
Hosts and Viruses
Volume
13
Publication date
31 March 2026
Language
EN